Published in Recent Pat DNA Gene Seq on January 01, 2008
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization. Mol Ther Nucleic Acids (2014) 1.21
Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. ACS Nano (2012) 0.91
Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis (2012) 0.90
Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis. BMC Infect Dis (2012) 0.80
Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat Biotechnol (2003) 4.03
Heterogeneous coding of temporally discounted values in the dorsal and ventral striatum during intertemporal choice. Neuron (2011) 1.72
Identification of novel universal housekeeping genes by statistical analysis of microarray data. J Biochem Mol Biol (2007) 1.64
The role of Bach2 in nucleic acid-triggered antiviral innate immune responses. Biochem Biophys Res Commun (2007) 1.34
Characterization of the interaction between neuronal RNA-binding protein HuD and AU-rich RNA. J Biol Chem (2003) 1.22
Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol (2007) 1.21
Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects. Mol Ther (2009) 1.19
Specific SR protein-dependent splicing substrates identified through genomic SELEX. Nucleic Acids Res (2003) 1.18
Predeliberation activity in prefrontal cortex and striatum and the prediction of subsequent value judgment. Front Neurosci (2013) 1.16
Normal structure, variations, and anomalies of the pancreaticobiliary ducts of Koreans: a nationwide cooperative prospective study. Gastrointest Endosc (2002) 1.14
Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Hum Pathol (2011) 1.13
Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma. Hepatol Res (2004) 1.12
Temporal discounting and inter-temporal choice in rhesus monkeys. Front Behav Neurosci (2009) 1.10
Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. Carcinogenesis (2012) 1.07
Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer (2005) 1.06
Solution structure of the complex formed by the two N-terminal RNA-binding domains of nucleolin and a pre-rRNA target. J Mol Biol (2004) 1.06
Nucleic acid aptamers targeting cell-surface proteins. Methods (2011) 1.06
Phosphorylation of the RNA polymerase II C-terminal domain by TFIIH kinase is not essential for transcription of Saccharomyces cerevisiae genome. Proc Natl Acad Sci U S A (2009) 1.04
Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis. J Cell Mol Med (2008) 1.03
Selection and elution of aptamers using nanoporous sol-gel arrays with integrated microheaters. Lab Chip (2009) 0.97
Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen. Biochem Biophys Res Commun (2007) 0.96
Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50. Mol Cancer Ther (2009) 0.93
Analysis of the effect of aging on the response to hypoxia by cDNA microarray. Mech Ageing Dev (2003) 0.92
Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins. Protein Expr Purif (2010) 0.92
Alkaline phosphatase ALPPL-2 is a novel pancreatic carcinoma-associated protein. Cancer Res (2013) 0.90
High diagnostic accuracy of antigen microarray for sensitive detection of hepatitis C virus infection. Clin Chem (2008) 0.89
Inflammatory cytokine induction by siRNAs is cell type- and transfection reagent-specific. Biochem Biophys Res Commun (2006) 0.89
Bilateral sacroiliac joint dislocation (anterior and posterior) with triradiate cartilage injury: a case report. J Orthop Trauma (2011) 0.88
Competition potency of siRNA is specified by the 5'-half sequence of the guide strand. Biochem Biophys Res Commun (2007) 0.87
Structural diversity repertoire of gene silencing small interfering RNAs. Nucleic Acid Ther (2011) 0.87
A sol-gel-based microfluidics system enhances the efficiency of RNA aptamer selection. Oligonucleotides (2011) 0.87
Dual-target gene silencing by using long, synthetic siRNA duplexes without triggering antiviral responses. Mol Cells (2009) 0.87
Development of single-stranded DNA aptamers for specific Bisphenol a detection. Oligonucleotides (2011) 0.87
Aptamer microarray mediated capture and mass spectrometry identification of biomarker in serum samples. J Proteome Res (2010) 0.84
Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects. Biochim Biophys Acta (2013) 0.84
Gene regulations in HBV-related liver cirrhosis closely correlate with disease severity. J Biochem Mol Biol (2007) 0.84
Enhanced intracellular delivery and multi-target gene silencing triggered by tripodal RNA structures. J Gene Med (2012) 0.84
Aptamer sandwich-based carbon nanotube sensors for single-carbon-atomic-resolution detection of non-polar small molecular species. Lab Chip (2010) 0.84
Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity. ACS Nano (2013) 0.84
HIF-1alpha-dependent gene expression program during the nucleic acid-triggered antiviral innate immune responses. Mol Cells (2009) 0.83
A structure-activity relationship study of siRNAs with structural variations. Biochem Biophys Res Commun (2007) 0.82
Sol-gel derived nanoporous compositions for entrapping small molecules and their outlook toward aptamer screening. Anal Chem (2012) 0.82
The diagnostic value of endoprobe for small esophageal leiomyomas derived from the muscularis mucosae. Yonsei Med J (2005) 0.82
Enhanced delivery of T cells to tumor after chemotherapy using membrane-anchored, apoptosis-targeted peptide. J Control Release (2012) 0.81
Branched, tripartite-interfering RNAs silence multiple target genes with long guide strands. Nucleic Acid Ther (2012) 0.80
Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide. PLoS One (2013) 0.80
Bilateral tenosynovial giant cell tumor of the knee accompanied by chronic ACL tear. J Orthop Sci (2011) 0.80
Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing. Mol Ther (2011) 0.80
A functional polymorphism in CSF1R gene is a novel susceptibility marker for lung cancer among never-smoking females. J Thorac Oncol (2014) 0.79
Identification of sequence features that predict competition potency of siRNAs. Biochem Biophys Res Commun (2010) 0.79
Long dsRNA-mediated RNA interference and immunostimulation: a targeted delivery approach using polyethyleneimine based nano-carriers. Mol Pharm (2014) 0.79
Long double-stranded RNA-mediated RNA interference and immunostimulation: long interfering double-stranded RNA as a potent anticancer therapeutics. Nucleic Acid Ther (2011) 0.78
Effects of physiochemical properties of test media on nanoparticle toxicity to Daphnia magna Straus. Bull Environ Contam Toxicol (2014) 0.78
Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial. J Med Food (2014) 0.77
Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells. PLoS One (2012) 0.77
A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma. Yonsei Med J (2005) 0.77
Selection and optimization of asymmetric siRNA targeting the human c-MET gene. Mol Cells (2011) 0.77
Sol-gel SELEX circumventing chemical conjugation of low molecular weight metabolites discovers aptamers selective to xanthine. Nucleic Acid Ther (2013) 0.76
The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells. Methods Mol Biol (2013) 0.76
Improved porous silicon microarray based prostate specific antigen immunoassay by optimized surface density of the capture antibody. Anal Chim Acta (2013) 0.76
Target gene abundance contributes to the efficiency of siRNA-mediated gene silencing. Nucleic Acid Ther (2014) 0.76
Differential polyubiquitin recognition by tandem ubiquitin binding domains of Rabex-5. Biochem Biophys Res Commun (2012) 0.76
SERS decoding of micro gold shells moving in microfluidic systems. Electrophoresis (2010) 0.75
RNA interference-mediated simultaneous silencing of four genes using cross-shaped RNA. Mol Cells (2013) 0.75
Effect of siRNA with an asymmetric RNA/dTdT overhang on RNA interference activity. Nucleic Acid Ther (2014) 0.75
Mid-term outcomes of floating platform mobile-bearing total knee arthroplasty under navigational guidance with a minimum 4-year follow-up. J Arthroplasty (2013) 0.75
Genetically encoded biosensors for the detection of rapamycin: toward the screening of agonists and antagonists. Analyst (2020) 0.75
Tuberculous arthritis of the knee joint mimicking pigmented villonodular synovitis. Knee Surg Sports Traumatol Arthrosc (2011) 0.75
A sol-gel-integrated protein array system for affinity analysis of aptamer-target protein interaction. Nucleic Acid Ther (2011) 0.75
Influence of gap balance on the sagittal movement of a specific mobile bearing floating platform design in total knee arthroplasty. J Arthroplasty (2013) 0.75
Binaral interaction and centrifugal input enhances spatial contrast in olfactory bulb activation. Eur J Neurosci (2007) 0.75
Recent patents on nucleic acid-based antiviral therapeutics. Recent Pat Antiinfect Drug Discov (2010) 0.75
Biomimetic sensor design. Nanoscale (2015) 0.75